Abstract:Natural products with polypharmacological profiles have demonstrated promise as novel therapeutics for various complex diseases, including cancer. Currently, many gaps exist in our knowledge of which compounds interact with which targets, and experimentally testing all possible interactions is infeasible. Recent advances and developments of systems pharmacology and computational (in silico) approaches provide powerful tools for exploring the polypharmacological profiles of natural products. In this review, we introduce recent progresses and advances of computational tools and systems pharmacology approaches for identifying drug targets of natural products by focusing on the development of targeted cancer therapy. We survey the polypharmacological and systems immunology profiles of five representative natural products that are being considered as cancer therapies. We summarize various chemoinformatics, bioinformatics and systems biology resources for reconstructing drug-target networks of natural products. We then review currently available computational approaches and tools for prediction of drug-target interactions by focusing on five domains: target-based, ligand-based, chemogenomics-based, network-based and omics-based systems biology approaches. In addition, we describe a practical example of the application of systems pharmacology approaches by integrating the polypharmacology of natural products and large-scale cancer genomics data for the development of precision oncology under the systems biology framework. Finally, we highlight the promise of cancer immunotherapies and combination therapies that target tumor ecosystems (e.g. clones or 'selfish' sub-clones) via exploiting the immunological and inflammatory 'side' effects of natural products in the cancer post-genomics era.

Transcriptome and Proteome Analyses of Drug Interactions with Natural Products

Network pharmacology approaches for research of Traditional Chinese Medicines

A Proteomic Landscape of Pharmacologic Perturbations for Functional Relevance

Research progress in drug toxicology based on systems biology

Unraveling the Molecular Targets of Natural Products: Insights from Genomic and Proteomic Analyses

Advances in computational approaches in identifying synergistic drug combinations.

Predicting and Quantifying Antagonistic Effects of Natural Compounds Given with Chemotherapeutic Agents: Applications for High-Throughput Screening

Application of omics- and multi-omics-based techniques for natural product target discovery

A network-based trans-omics approach for predicting synergistic drug combinations

How Can Synergism of Traditional Medicines Benefit from Network Pharmacology?

Network Pharmacology: Exploring the Resources and Methodologies.

What Does It Take to Synergistically Combine Sub-Potent Natural Products into Drug-Level Potent Combinations?

Synergy evaluation by a pathway-pathway interaction network: a new way to predict drug combination.

Proteomics approach to illustrate drug action mechanisms.

Exploring Drug Combinations in Genetic Interaction Network

Using Natural Products for Drug Discovery: the Impact of the Genomics Era

In silico polypharmacology of natural products.

Integration of high-throughput omics technologies in medicinal plant research: The new era of natural drug discovery

Chemical proteomics accelerates the target discovery of natural products

Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases

Mechanisms of Drug Combinations: Interaction and Network Perspectives.